868055-18-9

Upstream product

• 1125-88-8 benzaldehyde dimethyl acetal 
• 138923-10-1 2-azido-4,6-O-benzylidene-2-deoxyl-1-O-tert-butyldimethylsilyl-β-D-glucopyranoside 
• 99049-65-7 tert-Butyldimethylsilyl-3,4,6-tri-O-acetyl-2-azido-2-desoxy-β-D-glucopyranosid 
• 99049-67-9 tert-Butyldimethylsilyl-2-azido-2-desoxy-β-D-glucopyranosid 
• 868055-01-0 2-azido-1,3,5,6-tetra-O-benzyl-2-deoxy-D-glucitol 
• 868054-99-3 2-azido-1,3,5-tri-O-benzyl-4,6-O-benzylidene-2-deoxy-D-glucitol 
• 914465-72-8 2-azido-4,6-O-benzylidene-2-deoxy-D-glucitol 

Downstream Products

• 868055-21-4 2-azido-1,3,5,6-tetra-O-benzyl-2-deoxy-4-O-(2-azido-3,4,6-tri-O-benzyl-2-deoxy-β-D-glucopyranosyl)-D-glucitol 

Relevant academic research and scientific papers

Synthesis of DTPA-conjugated (1,4)-linked 2-aminoglycosides varying in the anomeric configuration and their MRI contrast effect

We describe the efficient synthesis of DTPA-conjugated oligosaccharides composed of α- and/ or β-linked tri to monoglucosamines. Gd(III) complex with DTPA-conjugated chitotriitol 1 has been reported to be an effective MRI contrast agent. In order to eluci